A practical guide to financing terms of a Life Sciences start-up

Date

26.03.2019 13:30 - 18:00

Location

Switzerland Innovation Park Basel Area AG, Gewerbestrasse 24, 4123 Allschwil

Register

Financing Biotech start-ups usually requires financial resources that exceed what founders can summon up. Bank loans are not appropriate for start-ups.

This means that addressing venture capital investors becomes necessary. The seminar will deal with typical terms of contracts between Business Angel investors as well as VCs and start-up companies (e.g. liquidation preference, anti-dilution provisions, ESOPs etc.) and considerations behind them. For start-ups seeking equity based financing it is of great interest to understand such language and know about the specifics of negotiation with venture capital investors.

Principal

Swiss Venture Capital Report

The new Swiss Venture Capital Report provides a review of the whole of 2023. In addition to investments, the report will once again include the results of a survey of Swiss investors, an overview of venture capital fundraising and a list of exits. You can download the Report in our asset section.